Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Open Neuroimag J ; 7: 53-7, 2013.
Article in English | MEDLINE | ID: mdl-24478812

ABSTRACT

Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder with an unpredictable clinical course and highly varied clinical presentation ranging from single system to multisystem involvement. Although head and neck involvement is common in LCH, isolated bilateral temporal bone involvement is exceedingly rare. Furthermore, LCH is commonly misinterpreted as mastoiditis, otitis media and otitis externa, delaying diagnosis and appropriate therapeutic management. To improve detection and time to treatment, it is imperative to have LCH in the differential diagnosis for unusual presentations of the aforementioned infectious head and neck etiologies. Any lytic lesion of the temporal bone identified by radiology should raise suspicion for LCH. We hereby describe the radiologic findings of a case of bilateral temporal bone LCH, originally misdiagnosed as mastoiditis.

2.
Circ Arrhythm Electrophysiol ; 5(4): 782-8, 2012 Aug 01.
Article in English | MEDLINE | ID: mdl-22787014

ABSTRACT

BACKGROUND: Treatment options for patients with recurrent ventricular arrhythmias refractory to pharmacotherapy and ablation are minimal. Although left cardiac sympathetic denervation (LCSD) is well established in long-QT syndrome, its role in non-long-QT syndrome arrhythmogenic channelopathies and cardiomyopathies is less clear. Here, we report our single-center experience in performing LCSD in this setting. METHODS AND RESULTS: In this institutional review board-approved study, we retrospectively reviewed the electronic medical records of all patients (N=91) who had videoscopic LCSD at our institution from 2005 to 2011. Data were analyzed for the subset (n=27) who were denervated for an underlying diagnosis other than autosomal dominant or sporadic long-QT syndrome. The spectrum of arrhythmogenic disease included catecholaminergic polymorphic ventricular tachycardia (n=13), Jervell and Lange-Nielsen syndrome (n=5), idiopathic ventricular fibrillation (n=4), left ventricular noncompaction (n=2), hypertrophic cardiomyopathy (n=1), ischemic cardiomyopathy (n=1), and arrhythmogenic right ventricular cardiomyopathy (n=1). Five patients had LCSD because of high-risk assessment and ß-blocker intolerance, none of whom had a sentinel breakthrough cardiac event at early follow-up. Among the remaining 22 previously symptomatic patients who had LCSD as secondary prevention, all had an attenuation in cardiac events, with 18 having no breakthrough cardiac events so far and 4 having experienced ≥1 post-LCSD breakthrough cardiac event. CONCLUSIONS: LCSD may represent a substrate-independent antifibrillatory treatment option for patients with life-threatening ventricular arrhythmia syndromes other than long-QT syndrome. The early follow-up seems promising, with a marked reduction in the frequency of cardiac events postdenervation.


Subject(s)
Endoscopy , Heart/innervation , Sympathectomy/methods , Sympathetic Nervous System/physiopathology , Tachycardia, Ventricular/surgery , Ventricular Fibrillation/surgery , Video-Assisted Surgery , Adolescent , Adult , Arrhythmogenic Right Ventricular Dysplasia/physiopathology , Arrhythmogenic Right Ventricular Dysplasia/surgery , Child , Child, Preschool , Disease-Free Survival , Endoscopy/adverse effects , Female , Humans , Infant , Isolated Noncompaction of the Ventricular Myocardium/physiopathology , Isolated Noncompaction of the Ventricular Myocardium/surgery , Jervell-Lange Nielsen Syndrome/physiopathology , Jervell-Lange Nielsen Syndrome/surgery , Kaplan-Meier Estimate , Male , Middle Aged , Minnesota , Recurrence , Retrospective Studies , Sympathectomy/adverse effects , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/physiopathology , Time Factors , Treatment Outcome , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/physiopathology , Video-Assisted Surgery/adverse effects , Young Adult
3.
Congenit Heart Dis ; 6(5): 492-8, 2011.
Article in English | MEDLINE | ID: mdl-21696549

ABSTRACT

Distinguishing congenital long QT syndrome from QT prolongation caused by drugs or a different underlying disease process is essential for selecting the proper treatment. Herein, we present a case of a patient referred for left cardiac sympathetic denervation as a last resort treatment option for her 19-year standing diagnosis of long QT syndrome with malignant ventricular fibrillation. However, based on her atypical clinical course and additional imaging studies, a diagnosis of left ventricular noncompaction, rather than long QT syndrome, was made. She left the clinic with a drastically different treatment plan and an improved quality of life. Because many cardiac and noncardiac diseases can demonstrate QT prolongation on electrocardiogram, all possible diagnoses should be considered before diagnosing a patient with congenital long QT syndrome especially with regard to the profound treatment implications and genetic follow-up in family members.


Subject(s)
Diagnostic Errors , Isolated Noncompaction of the Ventricular Myocardium/diagnosis , Long QT Syndrome/diagnosis , Ventricular Fibrillation/diagnosis , Adult , Anti-Arrhythmia Agents/therapeutic use , Cardiac Pacing, Artificial , Defibrillators, Implantable , Electric Countershock/instrumentation , Electrocardiography , Female , Humans , Isolated Noncompaction of the Ventricular Myocardium/complications , Isolated Noncompaction of the Ventricular Myocardium/therapy , Long QT Syndrome/congenital , Predictive Value of Tests , Tomography, X-Ray Computed , Treatment Outcome , Ventricular Fibrillation/etiology , Ventricular Fibrillation/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...